Aragen Biologics Private Limited - Company Profile

It is a pharma private limited company based in Uppal, Telangana, India, established in 2023.

2023 Uppal, Telangana, India Active

Last Updated: February 26, 2026

About Aragen Biologics Private Limited

Aragen Biologics Private Limited, a active private limited company, was established on 21 June 2023 in Uppal, Telangana, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U21001TS2023PTC174243. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹300.00 Cr and a paid-up capital of ₹299.94 Cr.

Its leadership includes Manmahesh Kantipudi (Non- Individual Subscriber), Robert Richard Ruffolo (Additional Director), Gunapati Reddy Venkat Keshav (Director). Past directors included Sachin Anand Dharap. It holds ₹140.00 Cr open charges and no settled loans. Its latest AGM occurred on 31 July 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No. 28A, Ida Nacharam, Uppal, Telangana, 500076.

Company Details

CIN/LLPIN
U21001TS2023PTC174243
Registration Number
174243
Incorporation Date
21 June 2023
Authorized Capital
₹300.00 Cr
Paid-Up Capital
₹299.94 Cr
ROC Code
Roc Hyderabad
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 300.00 Cr as on 26-02-2026
Paid Up Capital ₹ 299.94 Cr as on 26-02-2026
Company Age 2 Year, 8 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 140.00 Cr as on 26-02-2026

Comprehensive Company Insights

Explore comprehensive insights into Aragen Biologics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Aragen Biologics Private Limited?

Current Directors

Name	Designation	Appointment Date	Status
Manmahesh Kantipudi	Non- Individual Subscriber	21 Jun 2023	Current
Robert Richard Ruffolo	Additional Director	03 Jul 2025	Current
Gunapati Reddy Venkat Keshav	Director	21 Jun 2023	Current
Subodh Shrinivas Deshmukh	Additional Director	28 Oct 2025	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Cfo	-	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Aragen Biologics.

Aragen Biologics Private Limited, for the financial year ended 2024, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

*******

Revenue from Operations

*******

Total Assets

*******

Profit or Loss

*******

Net Worth

*******

EBITDA

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Aragen Biologics?

In 2024, Aragen Biologics had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹1,400,000,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions

Citi Bank N.A. : 140.00 Cr

Latest Charge Details

Date	Lender	Amount	Status
30 May 2024	Citi Bank N.A.	₹120.00 Cr	Open
30 May 2024	Citi Bank N.A.	₹20.00 Cr	Open

Explore comprehensive loan charge details -

How Many Employees Work at Aragen Biologics?

Unlock and access historical data on people associated with Aragen Biologics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Aragen Biologics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aragen Biologics's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Aragen Biologics

Recent Activity within the Organization

Director Appointment

The activity Subodh Shrinivas Deshmukh was appointed as a Additional Director was appointed as a Additional Director on 28 Oct 2025 & has been associated with this company since 4 months 15 days . was completed.
28 Oct 2025
Annual General Meeting

Progress on Aragen Biologics Private Limited last Annual general meeting of members was held on 31 Jul 2025 as per latest MCA records. was documented.
31 Jul 2025
Director Appointment

Robert Richard Ruffolo was appointed as a Additional Director was appointed as a Additional Director on 03 Jul 2025 & has been associated with this company since 8 months 9 days . was recorded as a recent event.
03 Jul 2025
Balance Sheet

Progress on Aragen Biologics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.
31 Mar 2025
Director Appointment

Progress on Ramakrishna Kasturi was appointed as a Company Secretary was appointed as a Company Secretary on 29 Oct 2024 & has been associated with this company since 1 year 4 months . was documented.
29 Oct 2024
Director Appointment

The activity Sachin Anand Dharap was appointed as a CFO was appointed as a CFO on 29 Oct 2024 & has been associated with this company since 1 year 4 months . was completed.
29 Oct 2024

Explore recent activity and updates - View Recent Activity